Patents by Inventor Kong Lam

Kong Lam has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Biologically active peptides and their new uses
    Patent number: 8703695
    Abstract: Novel peptides are disclosed with their use as a pharmaceutical composition. A method is also disclosed for making pharmaceutical compositions and treatment of an individual.
    Type: Grant
    Filed: February 21, 2013
    Date of Patent: April 22, 2014
    Assignee: CMS Peptides Patent Holding Company Limited
    Inventors: Wai Ming Wong, Kong Lam
  • Biologically active peptides and their new uses
    Patent number: 8658592
    Abstract: Novel peptides are disclosed with their use as a pharmaceutical composition. A method is also disclosed for making pharmaceutical compositions and treatment of an individual.
    Type: Grant
    Filed: February 21, 2013
    Date of Patent: February 25, 2014
    Assignee: CMS Peptides Patent Holding Company Limited
    Inventors: Wai Ming Wong, Kong Lam
  • Biologically active peptides and their new uses
    Patent number: 8586528
    Abstract: Novel peptides are disclosed with their use as a pharmaceutical composition. A method is also disclosed for making pharmaceutical compositions and treatment of an individual.
    Type: Grant
    Filed: March 7, 2012
    Date of Patent: November 19, 2013
    Inventors: Wai Ming Wong, Kong Lam
  • Biologically active peptides and their new uses
    Patent number: 8586525
    Abstract: Novel peptides are disclosed with their use as a pharmaceutical composition. A method is also disclosed for making pharmaceutical compositions and treatment of an individual.
    Type: Grant
    Filed: July 21, 2006
    Date of Patent: November 19, 2013
    Assignee: CMS Peptides Patent Holding Company Limited
    Inventors: Wai Ming Wong, Kong Lam
  • NOVEL BIOLOGICALLY ACTIVE PEPTIDES AND THEIR NEW USES
    Publication number: 20130190241
    Abstract: Novel peptides are disclosed with their use as a pharmaceutical composition. A method is also disclosed for making pharmaceutical compositions and treatment of an individual.
    Type: Application
    Filed: February 21, 2013
    Publication date: July 25, 2013
    Applicant: CMS Peptides Patent Holding Company Limited
    Inventors: Wai Ming WONG, Kong LAM
  • NOVEL BIOLOGICALLY ACTIVE PEPTIDES AND THEIR NEW USES
    Publication number: 20130190255
    Abstract: Novel peptides are disclosed with their use as a pharmaceutical composition. A method is also disclosed for making pharmaceutical compositions and treatment of an individual.
    Type: Application
    Filed: February 21, 2013
    Publication date: July 25, 2013
    Applicant: CMS Peptides Patent Holding Company Limited
    Inventors: Wai Ming WONG, Kong LAM
  • Novel Biologically Active Peptides and their New Uses
    Publication number: 20120171234
    Abstract: Novel peptides are disclosed with their use as a pharmaceutical composition. A method is also disclosed for making pharmaceutical compositions and treatment of an individual.
    Type: Application
    Filed: March 7, 2012
    Publication date: July 5, 2012
    Applicant: CMS PEPTIDES PATENT HOLDING COMPANY LIMITED
    Inventors: Wai Ming Wong, Kong Lam
  • Biologically active peptide VAPEEHPTLLTEAPLNPK derivatives
    Patent number: 7718764
    Abstract: Peptides derived from the peptide CMS-010, which has the formula VAPEEHPTLLTEAPLNPK, are disclosed with their use as pharmaceutical compositions. A method is also disclosed for making a pharmaceutical composition comprising providing a peptide derived from CMS-010 and mixing said peptide with a pharmaceutical acceptable carrier.
    Type: Grant
    Filed: April 25, 2005
    Date of Patent: May 18, 2010
    Assignee: CMS Peptides Patent Holding Company Limited
    Inventors: Wai Ming Wong, Kong Lam
  • Biologically active peptide PTTKTYFPHF
    Patent number: 7718768
    Abstract: Thirty substantially pure and biologically active peptides are disclosed. Nucleic acids that have sequences coding for the biologically active peptides and pharmaceutical formulations produced therefrom are also disclosed.
    Type: Grant
    Filed: July 18, 2006
    Date of Patent: May 18, 2010
    Assignee: CMS Peptides Patent Holding Company Limited
    Inventors: Wai Ming Wong, Kong Lam
  • Biologically active peptide consisting of tyrosyl-seryl-leucine (YSL)
    Patent number: 7696152
    Abstract: A substantially pure and biologically active peptides consisting of tyrosyl-seryl-leucine (YSL) is disclosed. Nucleic acids that have sequences coding for the biologically active peptide and pharmaceutical formulation produced therefrom are also disclosed.
    Type: Grant
    Filed: July 31, 2006
    Date of Patent: April 13, 2010
    Assignee: CMS Peptides Patent Holdings Company Limited
    Inventors: Wai Ming Wong, Kong Lam
  • Biologically active peptide comprising tyrosyl-seryl-valine (YSV)
    Patent number: 7666986
    Abstract: The tripeptide Tyrosyl-seryl-valine is disclosed with its use as a nutritional supplement. A method of making a nutritional supplement comprising obtaining the tripeptide Tyrosyl-seryl-valine and mixing the tripeptide with a biologically or therapeutically acceptable carrier is also disclosed.
    Type: Grant
    Filed: October 31, 2007
    Date of Patent: February 23, 2010
    Assignee: CMS Peptides Patent Holding Company Limited
    Inventors: Wai Ming Wong, Kong Lam
  • Compositions comprising the biologically active peptide YSL
    Patent number: 7491689
    Abstract: Thirty substantially pure and biologically active peptides are disclosed. Nucleic acids that have sequences coding for the biologically active peptides and pharmaceutical formulations produced thereform are also disclosed.
    Type: Grant
    Filed: September 5, 2002
    Date of Patent: February 17, 2009
    Assignee: CMS Peptides Patent Holding Company Limited
    Inventors: Wai Ming Wong, Kong Lam
  • BIOLOGICALLY ACTIVE PEPTIDES
    Publication number: 20080293641
    Abstract: Thirty substantially pure and biologically active peptides are disclosed. Nucleic acids that have sequences coding for the biologically active peptides and pharmaceutical formulations produced therefrom are also disclosed.
    Type: Application
    Filed: March 17, 2008
    Publication date: November 27, 2008
    Inventors: Wai Ming WONG, Kong Lam
  • Biologically Active Peptides
    Publication number: 20080233136
    Abstract: Thirty substantially pure and biologically active peptides are disclosed. Nucleic acids that have sequences coding for the biologically active peptides and pharmaceutical formulations produced therefrom are also disclosed.
    Type: Application
    Filed: July 31, 2006
    Publication date: September 25, 2008
    Inventors: Wai Ming WONG, Kong Lam
  • Biologically active peptide comprising Tyrosyl-seryl-valine(YSV)
    Patent number: 7427599
    Abstract: The tripeptide Tyrosyl-seryl-valine is disclosed with its use as a pharmaceutical composition in treating a condition whose effects can be reduced by stimulating T-cell transformation and a cell proliferative disorder. A method is also disclosed making a pharmaceutical composition comprising providing the tripeptide Tyrosyl-seryl-valine and mixing said tripeptide with a pharmaceutical acceptable carrier.
    Type: Grant
    Filed: June 22, 2004
    Date of Patent: September 23, 2008
    Assignee: CMS Peptides Patent Holding Company Limited
    Inventors: Wai Ming Wong, Kong Lam
  • Novel Biologically Active Peptides and Their New Uses
    Publication number: 20080214469
    Abstract: Novel peptides are disclosed with their use as a pharmaceutical composition. A method is also disclosed for making pharmaceutical compositions and treatment of an individual.
    Type: Application
    Filed: July 21, 2006
    Publication date: September 4, 2008
    Inventors: Kong Lam, Wai Ming Wong
  • Biologically active peptides
    Patent number: 7402653
    Abstract: Thirty substantially pure and biologically active peptides are disclosed. Nucleic acids that have sequences coding for the biologically active peptides and pharmaceutical formulations produced thereform are also disclosed.
    Type: Grant
    Filed: June 16, 2006
    Date of Patent: July 22, 2008
    Assignee: CMS Peptides Patent Holding Company Limited
    Inventors: Wai Ming Wong, Kong Lam
  • Biologically active peptides comprising Isoleucyl-valyl-threonyl-asparaginyl-threonyl-threonine (IVTNTT)
    Patent number: 7396817
    Abstract: The peptide Isoleucyl-valyl-threonyl-asparaginyl-threonyl-threonine (SEQ ID NO.1) is disclosed with its use as a pharmaceutical composition in reducing symptoms of viral disease and stimulating properties of immune system in a subject. A method is also disclosed for making a pharmaceutical composition comprising providing an Isoleucyl-valyl-threonyl-asparaginyl-threonyl-threonine (SEQ ID NO.1) peptide and mixing said peptide with a pharmaceutical acceptable carrier.
    Type: Grant
    Filed: November 18, 2004
    Date of Patent: July 8, 2008
    Assignee: CMS Peptides Patent Holding Company Limited
    Inventors: Wai Ming Wong, Kong Lam
  • Automated ball mounting process and system with solder ball testing
    Patent number: 7392924
    Abstract: An automated ball mounting system is disclosed In which solder balls are tested by heating the solder balls to a temperature between the eutectic temperature of lead-tin and the melting temperature of a lead free solder ball. If the heated solder balls melt they are standard solder balls. If they do not melt they are lead free solder balls. Solder balls that are input into the automated ball mounting process are automatically tested to determine solder ball type. When the test indicates that the wrong type of solder ball is being used an error message is indicated and the solder ball mounting process stops.
    Type: Grant
    Filed: November 16, 2004
    Date of Patent: July 1, 2008
    Assignee: Integrated Device Technology, Inc.
    Inventors: Kong Lam Song, Peng Cheong Choe, Tic Medina
  • Automated ball mounting process with solder ball testing
    Patent number: 7390122
    Abstract: An automated ball mounting process is disclosed in which solder balls are tested by heating the solder balls to a temperature between the eutectic temperature of lead-tin and the melting temperature of a lead free solder ball. If the heated solder balls melt they are standard solder balls. If they do not melt they are lead free solder balls. Solder balls that are input into the automated ball mounting process are automatically tested to determine solder ball type. When the test indicates that the wrong type of solder ball is being used an error message is indicated and the solder ball mounting process stops.
    Type: Grant
    Filed: October 31, 2007
    Date of Patent: June 24, 2008
    Assignee: Integrated Device Technology, Inc.
    Inventors: Kong Lam Song, Peng Cheong Choe, Tic Medina